Table 4.

Summary of other NA study referring to the main results.

References	Follow-up (mo) Median (min–max)	NBA (n)			BA (n)
		Total	Death	Recurrence	Total	Death	Recurrence
Binnetoglu et al. (9)	15.00 (3.00–72.00)	31	2 of SVT died because of respiratory problem, 1 of complete AV block died because of sepsis	5 of SVT	35	1 of PAC died because of metabolic disease	—
Kundak et al. (11)	—	55	3 of SVT, 4 of complete AV block, 4 of VT, 2 of mixed-type arrhythmia	—	—	—	—
Isik et al. (10)	—	9	1 of SVT died because of chronic lung disease	3 of SVT	8	0	0
Moura et al. (5)	30.80 (0.00–71.00)	26	1 of complete AV block died because of cerebral hemorrhage	2 of SVT	—	—	—
Gilljam et al. (8)	6.00 (0.00–189.60)	109	7 of SVT (4 of heart failure, 1 of premature, 2 of structural heart disease, 1 of pulmonary vascular disease)	13 of SVT	—	—	—
Mou et al. (18)	—	46	3	—	271	0	—
Wang et al. (19)	3.00	38	1 of SVT died because of heart failure, 2 of VT died because of shock	—	51	0	—
Casey et al. (20)	Median 23.00	18	2 of AFL	0	—	—	—
Davis et al. (21)	25.20 (0.00–169.20)	40	6 of VT	—	—	—	—
Eliasson et al. (22)	38.40 (1.00–97.20)	175	14 of complete AV block	—	—	—	—
Total	10 literatures	547	53	23	365	1	0

NA, neonatal arrhythmia; NBA, non-benign arrhythmia; BA, benign arrhythmia; SVT, supraventricular tachycardia; VT, ventricular tachycardia; AFL, atrial flutter; AV, atrioventricular; PAC, premature atrial contraction.